Latest news
Autodesk (ADSK): New Buy Recommendation for This Technology Giant - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 13:06:00 GMTCCORF Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $153 - MoomooMoomoo · Thu, 06 Aug 2026 11:31:00 GMTNektar’s Phase 3 Eczema Trial Moves Forward: What Investors Should Watch - TipRanksTipRanks · Tue, 04 Aug 2026 16:48:52 GMT